Rachelle Suzanne Jacques
CIK 1772610 · Chief Executive Officer · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$215.97M
Companies
4
Total Filings
25
Lifetime Open-Market Net
-$146.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QURE | Director | 35,896 | $36.66 | $1.32M | -$146.7K | 10 | 2026-06-12 |
| CRBP | Director | 11,383 | $9.09 | $103.4K | $0 | 10 | 2026-05-21 |
| AKTX | Chief Executive Officer | 25,450,695 | $8.43 | $214.55M | $0 | 1 | 2024-04-30 |
| Viela Bio, Inc. (VIE) Delisted | Director | — | — | — | $0 | 3 | 2021-03-15 |
Recent Filings · Page 2 of 3
25 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-04-30 | AKTX | Grant (A) | +479,569,892 | $0 | EDGAR |
| 2023-06-20 | QURE | Mixed | +6,399 | -$43.2K | EDGAR |
| 2023-05-22 | CRBP | Grant (A) | — | $0 | EDGAR |
| 2023-03-01 | QURE | Sell (S) | −384 | -$7.7K | EDGAR |
| 2022-06-17 | QURE | Grant (A) | +9,080 | $0 | EDGAR |
| 2022-05-19 | CRBP | Grant (A) | — | $0 | EDGAR |
| 2022-02-28 | QURE | Grant (A) | +1,534 | $0 | EDGAR |
| 2021-10-22 | QURE | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | CRBP | Grant (A) | — | $0 | EDGAR |
| 2021-03-15 | Viela Bio, Inc. (VIE) Delisted | Disp (D) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.